Korea University Anam Hospital Optical Coherence Tomography Registry
November 14, 2016 updated by: Dr. Cheol Woong Yu, Korea University Anam Hospital
Optical Coherence Tomography Registry of Korea University Anam Hospital
All comer registry who had undergone intravascular optical coherence tomography during and/or after coronary intervention.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Optical coherence tomography registry is composed with before coronary stenting, immediate after coronary stenting and follow-up study.
Study Type
Observational
Enrollment (Anticipated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 136-705
- Recruiting
- Korea University Anam Hospital
-
Contact:
- Cheol Woong Yu, M.D., Ph.D.
- Phone Number: +82-2-920-6726
- Email: ycw717@naver.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All comer registry with patients who had undergone coronary intervention and optical coherence tomography
Description
Inclusion Criteria:
- patients who had undergone coronary intervention and optical coherence tomography
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Optical Coherence Tomography registry group
Patients who had undergone optical coherence tomography within coronary intervention
|
Intracoronary imaging device which can precisely observe intracoronary structures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of participants with Major Adverse Cardiovascular Events (MACE)
Time Frame: Up to 10 years
|
Composite of non-fatal myocardial infarction, all cause death, target vessel revascularization
|
Up to 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Do-Sun Lim, MD, PhD, Korea University Anam Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
April 25, 2016
First Submitted That Met QC Criteria
November 14, 2016
First Posted (Estimate)
November 17, 2016
Study Record Updates
Last Update Posted (Estimate)
November 17, 2016
Last Update Submitted That Met QC Criteria
November 14, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KUMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.